Edition:
India

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

2.76USD
19 Jan 2018
Change (% chg)

-- (--)
Prev Close
$2.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
267,461
52-wk High
$3.93
52-wk Low
$2.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 3.92 -0.203
Jun '17 3.83 -0.228
Mar '17 1.53 -0.279
FY 2016 Dec '16 1.87 -0.299
Sep '16 2.22 -0.294
Jun '16 1.39 -0.323
Mar '16 1.30 -0.351
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 1.50 1.50 1.50 --
Quarter Ending Jun-18 1 1.50 1.50 1.50 --
Year Ending Dec-18 7 16.86 56.00 0.00 27.25
Earnings (per share)
Quarter Ending Mar-18 1 -0.22 -0.22 -0.22 --
Quarter Ending Jun-18 1 -0.23 -0.23 -0.23 --
Year Ending Dec-18 7 -0.90 -0.59 -1.09 -1.06
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 23.83 18.18 -6.04
EPS (TTM) % 3.41 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Celldex Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 21.54 17.35 83 --
13 Week 25.40 19.29 80 --
26 Week -4.24 -11.52 49 --
52 Week -24.76 -36.23 32 --
YTD -10.73 -21.61 34 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 54.20%
# of Holders: 177
Total Shares Held: 73,709,631
3 Mo. Net Change: -20,910
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 10
# Reduced Positions: 3
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.